Codetta Bio
Morrisville, US · Founded 2021 · Delaware corporation · 2 known investors
Find your way into Codetta Bio
Codetta Bio develops multiplex biomarker detection technology that combines digital PCR, real-time PCR, and immunoPCR with microbead-based target capture to simultaneously measure proteins, DNA, and RNA from a single sample. Its tools serve multi-omics research and life sciences applications.
Founders & leadership
Codetta Bio was founded in 2021 by Michael Ramsey.
MR
Michael RamseyCo-Founder
JC
Jacques CorriveauinPresident and CEOJacques Corriveau has over 25 years of experience in biopharma and diagnostics, with roles spanning commercial strategy, operations, and go-to-market development for genomics and cell-based platforms. He is Executive Officer and Director at Codetta Bio.
WH
William Hampton HenleyExecutive
JM
J. Michael RamseyinScience Co-Founder, Director, and Consultant
Board
Investors · 2
Reported raises · per SEC filings
Form D private placements$12.3M disclosed across 1 round · 2024
▶$12.3MraisedOct 2024 · 4 investors · BiotechnologyRule 506(b)
▶$12.3MraisedOct 2024 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jacques CorriveauExecutive Officer, Director
- William Hampton HenleyExecutive Officer
- John HoDirector
- J. Michael RamseyDirector
- Offering amount
- $26.4M
- Amount sold
- $12.3M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 9
by search overlapConcertobio5 shared keywordsConcerto Bio generates large-scale ecological datasets on microbial communities and uses them to develop microbe-based consumer health products for applications such as skincare, chronic disease, and nutrition. Its approach combines high-throughput experimental data generation with predictive modeling to make microbial communities engineerable.
bio4 shared keywordsBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Synata Bio4 shared keywordsSynata Bio develops customizable technology solutions for hydrogen and carbon economies, enabling hard-to-abate industries to achieve decarbonization targets while reducing carbon emissions and creating value from waste resources.
Taconic Biosciences4 shared keywordsTaconic Biosciences provides genetically engineered mouse and rat models, humanized immune system mice, custom model generation, colony management, and in vivo research services. It serves drug discovery and preclinical researchers, offering integrated laboratory animal models and services from model selection through study-ready cohorts.
Ditto Biosciences4 shared keywordsDitto Bio uses AI to identify protein candidates from parasites and pathogens for treating autoimmune diseases. The company mines natural compounds from viruses, ticks, and worms whose immune-modulating properties have evolved over millions of years.
Octave3 shared keywordsOctave develops blood-based biomarker tests for neurodegenerative diseases including multiple sclerosis, Parkinson's disease, and Alzheimer's disease. The company's tests enable physicians and patients to measure disease progression and treatment response through blood draws rather than traditional clinical assessments.
Tagbio3 shared keywordsTag.bio provides a data mesh platform for building and deploying governed data products in healthcare and life sciences. The platform enables secure data collaboration, AI model development, and multi-modal data integration for researchers, data scientists, and domain experts across biomedical organizations.
Predictabiosciences3 shared keywordsPredicta Biosciences operates a molecular insights platform for blood cancer care, using whole genome sequencing of intact circulating tumor cells from a single blood sample combined with single-cell immune profiling to characterize disease biology and immune response. Its diagnostics serve clinicians, researchers, and pharmaceutical partners working in hematological malignancies such as multiple myeloma.
Vedanta Biosciences3 shared keywordsVedanta Biosciences is a clinical-stage biotech developing Live Biotherapeutic Products (LBP) based on defined consortia of bacteria to treat serious gastrointestinal diseases, with an initial focus on preventing recurrent Clostridium difficile infection. Its oral therapies target gut dysbiosis-driven conditions.
Companies competing with Codetta Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Codetta Bio do?
- Codetta Bio develops multiplex biomarker detection technology that combines digital PCR, real-time PCR, and immunoPCR with microbead-based target capture to simultaneously measure proteins, DNA, and RNA from a single sample. Its tools serve multi-omics research and life sciences applications.
- Who founded Codetta Bio?
- Codetta Bio was founded by Michael Ramsey in 2021.
- Who are Codetta Bio's investors?
- Codetta Bio's investors include Bantam Group, Genoa Ventures.
- How much funding has Codetta Bio raised?
- Codetta Bio has disclosed $12.3M raised across 1 round.
- Where is Codetta Bio headquartered?
- Codetta Bio is headquartered in Morrisville, US.